Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, producing pronounced effects on body weight and metabolic regulation
Ozempic (semaglutide) is a brand-name drug approved by the Food and Drug Administration (FDA) for the following uses: to help manage blood sugar levels in people with type 2 diabetes, along with diet and exercise to reduce the risk of heart attack and stroke in adults with type 2 diabetes and cardiovascular disease to reduce the risk of complications from chronic kidney disease in adults with type 2 diabetes A doctor may also prescribe Ozempic off-label for weight loss, though the FDA has not approved it for this use
Concentration, stability, degradation, pH, excipients, route of exposure, impurities, and interactions can all affect experimental outcomes
PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R (receptor sensitivity) and FTO (metabolic regulation), providing insights into your likely appetite-response timeline and medication responsiveness